Experiencia de 20 años en el control de la hipertensión arterial en un centro de salud en Españacontrol estricto versus no estricto (Pag.-e 101999)

  1. D. Muíño-Domínguez 1
  2. L. Gómez-Sánchez 2
  3. V. Gallego-Fernández 2
  4. T. Seoane-Pillado 3
  5. X.L. López-Álvarez 2
  1. 1 Hospital Universitario Central de Asturias, Oviedo, Asturias, España
  2. 2 Centro de Saúde Mariñamansa, Ourense, España
  3. 3 Universidad de A Coruña, Instituto de Investigación Biomédica de A Coruña (INIBIC), A Coruña, España
Mostrar afiliacións +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2023

Número: 6

Páxinas: 4-4

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2023.101999 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Obxectivos de Desenvolvemento Sustentable

Resumo

Introducción y objetivos En los ensayos clínicos la reducción eficaz de la presión arterial (PA) produce una disminución de la incidencia de la morbimortalidad cardiovascular (CV). Nuestro objetivo principal es conocer si en las condiciones reales de la práctica clínica el control de la PA reduce a largo plazo los eventos CV. Pacientes y métodos El estudio se realizó en 164 pacientes con hipertensión arterial (HTA) elegidos entre los pacientes que acudían a las consultas de medicina de familia por HTA. Se hizo un análisis entre los pacientes que presentaban una PA clínica inferior a 140/90 mmHg y los que la tenían más elevada. Los pacientes se seguían hasta que se producía un evento CV o hasta un máximo de 20 años, en que se finalizaba el seguimiento. Resultados Del total de los 164 pacientes alcanzaron un buen control clínico de la HTA 93 (56,7%) pacientes y no lo alcanzaron 71 (42,2%). En el análisis multivariante quedó únicamente como variable predictora de eventos CV la falta de control estricto de la HTA (HR: 2,93; IC 95%: 1,45-5,89; p = 0,003), y el sexo femenino fue protector para eventos CV (HR: 0,37; IC 95%: 0,18-0,74; p = 0,005) Conclusiones La variable predictora fundamental de morbimortalidad CV en pacientes con HTA es la falta de control estricto de la HTA; las mujeres también tuvieron menos complicaciones CV.

Referencias bibliográficas

  • E. Menéndez, E. Delgado, F. Fernández-Vega, M.A. Prieto, E. Bordiú, A. Calle, et al. Prevalence, diagnosis, treatment, and control of hypertension in Spain. Results of the Di@bet.es Study Rev Esp Cardiol (Engl Ed)., 69 (2016), pp. 572-578 View PDFView articleView in ScopusGoogle Scholar
  • P. Muntner, R.M. Carey, S. Gidding, D.W. Jones, S.J. Taler, J.T. Wright, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline Circulation, 137 (2018), pp. 109-118 View PDFView articleView in ScopusGoogle Scholar
  • S.S. Yoon, Q. Gu, T. Nwankwo, J.D. Wright, Y. Hong, V. Burt Trends in blood pressure among adults with hypertension: United States, 2003 to 2012 Hypertension, 65 (2015), pp. 54-61 View PDF This article is free to access. View in ScopusGoogle Scholar
  • P.W. Wilson Established risk factors and coronary artery disease: The Framingham Study Am J Hypertens, 7 (1994), pp. 7S-12S View article CrossRefGoogle Scholar
  • P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey Jr., K.J. Collins, C. Dennison Himmelfarb, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension, 71 (2018), pp. 1269-1324 View article CrossRefView in ScopusGoogle Scholar
  • R. Jackson, C.M. Lawes, D.A. Bennett, R.J. Milne, A. Rodgers Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk Lancet, 365 (2005), pp. 434-441 View PDFView articleView in ScopusGoogle Scholar
  • A.C. Flint, C. Conell, X. Ren, N.M. Banki, S.L. Chan, V.A. Rao, et al. Effect of systolic and diastolic blood pressure on cardiovascular outcomes N Engl J Med, 381 (2019), pp. 243-251 View article CrossRefView in ScopusGoogle Scholar
  • D.K. Arnett, R.S. Blumenthal, M.A. Albert, A.B. Buroker, Z.D. Goldberger, E.J. Hahn, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideline Circulation., 140 (2019), pp. e563-e595 View in ScopusGoogle Scholar
  • E. Vidal-Petiot, N. Greenlaw, I. Ford, R. Ferrari, K.M. Fox, J.C. Tardif, et al. Relationships between components of blood pressure and cardiovascular events in patients with stable coronary artery disease and hypertension Hypertension, 71 (2018), pp. 168-176 View in ScopusGoogle Scholar
  • S. Cinza Sanjurjo, J.L. Llisterri Caro, A. Barquilla García, J. Polo García, S. Velilla Zancada, G.C. Rodríguez Roca, et al. Description of the sample, design and methods of the study for the identification of the Spanish population at cardiovascular and renal risk (IBERICAN) Semergen., 46 (2020), pp. 4-15 View PDFView articleView in ScopusGoogle Scholar
  • S. Cinza Sanjurjo, M.Á. Prieto Díaz, J.L. Llisterri Caro, V. Pallarés Carratalá, A. Barquilla García, L. Rodríguez Padial, et al. Baseline characteristics and clinical management of the first 3,000 patients enrolled in the IBERICAN study (Identification of the Spanish population at cardiovascular and renal risk) Semergen., 43 (2017), pp. 493-500 View PDFView articleView in ScopusGoogle Scholar
  • V. Barrios, C. Escobar, J.L. Llisterri, G. Rodríguez Roca, J.J. Badimón, J. Vergara, et al. Baseline clinical characteristics and management of patients included in IBERICAN study Semergen., 41 (2015), pp. 3-12 View PDFView articleView in ScopusGoogle Scholar
  • J.L. Llisterri, R.M. Micó-Pérez, S. Velilla-Zancada, G.C. Rodríguez-Roca, M.A. Prieto-Díaz, V. Martín-Sánchez, et al. Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: Results of the IBERICAN study Med Clin (Barc)., 156 (2021), pp. 157-165 View PDFView articleView in ScopusGoogle Scholar
  • S. Cinza-Sanjurjo, R.M. Micó-Pérez, S. Velilla-Zancada, M.A. Prieto-Díaz, G.C. Rodríguez-Roca, A. Barquilla García, et al. Factors associated with cardiovascular risk and cardiovascular and renal disease in the IBERICAN study: Final results Semergen., 46 (2020), pp. 368-378 View PDFView articleView in ScopusGoogle Scholar
  • W. Zhang, S. Zhang, Y. Deng, S. Wu, J. Ren, G. Sun, et al. Trial of intensive blood-pressure control in older patients with hypertension N Engl J Med., 385 (2021), pp. 1268-1279 View article CrossRefView in ScopusGoogle Scholar
  • J.D. Williamson, M.A. Supiano, W.B. Applegate, D.R. Berlowitz, R.C. Campbell, G.M. Chertow, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: A randomized clinical trial JAMA., 315 (2016), pp. 2673-2682 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • X. Xie, E. Atkins, J. Lv, A. Bennett, B. Neal, T. Ninomiya, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: Updated systematic review and meta-analysis Lancet, 387 (2016), pp. 435-443 View PDFView articleView in ScopusGoogle Scholar
  • L. Hansson, A. Zanchetti, HOT Study Group Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lancet, 351 (1998), pp. 1755-1762 View PDFView articleView in ScopusGoogle Scholar
  • L.C. Saiz, J. Gorricho, J. Garjón, M.C. Celaya, J. Erviti, L. Leache Blood pressure targets for the treatment of people with hypertension and cardiovascular disease Cochrane Database Syst Rev., 7 (2018) CD010315 Google Scholar
  • M. Böhm, H. Schumacher, K.K. Teo, E.M. Lonn, F. Mahfoud, J.F.E. Mann, et al. Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials Lancet, 389 (2017), pp. 2226-2237 View PDFView articleView in ScopusGoogle Scholar
  • E.M. Lonn, J. Bosch, P. López-Jaramillo, J. Zhu, L. Liu, P. Pais, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease N Engl J Med, 374 (2016), pp. 2009-2020 View article CrossRefView in ScopusGoogle Scholar
  • D. Ettehad, C.A. Emdin, A. Kiran, S.G. Anderson, T. Callender, J. Emberson, et al. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis Lancet., 387 (2016), pp. 957-967 View PDFView articleView in ScopusGoogle Scholar
  • M. Brunström, B. Carlberg Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: A systematic review and meta-analysis JAMA Intern Med., 178 (2018), pp. 28-36 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • B. Williams, G. Mancia, W. Spiering, E. Agabiti Rosei, M. Azizi, M. Burnier, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) Eur Heart J., 39 (2018), pp. 3021-3104 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • E. Falaschetti, J. Mindell, C. Knott, N. Poulter Hypertension management in England: A serial cross-sectional study from 1994 to 2011 Lancet., 383 (2014), pp. 1912-1919 View PDFView articleView in ScopusGoogle Scholar
  • D. Canoy, E. Copland, M. Nazarzadeh, R. Ramakrishnan, A.C. Pinho-Gomes, A. Salam, et al. Antihypertensive drug effects on long-term blood pressure: An individual-level data meta-analysis of randomised clinical trials Heart., 108 (2022), pp. 1281-1289 View article CrossRefGoogle Scholar
  • S. Lewington, R. Clarke, N. Qizilbash, R. Peto, R. Collins, Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies Lancet, 360 (2002), pp. 1903-1913 View PDF Your institution provides access to this article. View in ScopusGoogle Scholar
  • T. Kahan Decisions about antihypertensive treatment should focus on reducing cardiovascular risk Lancet., 397 (2021), pp. 1598-1599 View PDFView articleView in ScopusGoogle Scholar
  • M. Volpe, C. Patrono The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile Eur Heart J., 42 (2021), pp. 2814-2815 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • G. Bakris, W. Ali, G. Parati ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison J Am Coll Cardiol., 73 (2019), pp. 3018-3026 View PDFView articleView in ScopusGoogle Scholar
  • T. Unger, C. Borghi, F. Charchar, N.A. Khan, N.R. Poulter, D. Prabhakaran, et al. 2020 International Society of Hypertension global hypertension practice guidelines J Hypertens, 38 (2020), pp. 1334-1357 View article CrossRefView in ScopusGoogle Scholar
  • J. Marrugat, P. Solanas, R. D’Agostino, L. Sullivan, J. Ordovas, F. Cordón, et al. Coronary risk estimation in Spain using a calibrated Framingham function Rev Esp Cardiol., 56 (2003), pp. 253-261 View PDFView articleView in ScopusGoogle Scholar
  • S. Sans, A.P. Fitzgerald, D. Royo, R. Conroy, I. Graham Calibrating the SCORE cardiovascular risk chart for use in Spain Rev Esp Cardiol., 60 (2007), pp. 476-485 View PDFView articleView in ScopusGoogle Scholar
  • F. Catalá-López, G. Sanfélix-Gimeno, C. García-Torres, M. Ridao, S. Peiró Control of arterial hypertension in Spain: A systematic review and meta-analysis of 76 epidemiological studies on 341632 participants J Hypertens., 30 (2012), pp. 168-176 Google Scholar
  • V. Barrios, C. Escobar, F.J. Alonso-Moreno, M.A. Prieto, V. Pallares, G. Rodríguez-Roca, et al. Evolution of clinical profile, treatment and blood pressure control in treated hypertensive patients according to the sex from 2002 to 2010 in Spain J Hypertens., 33 (2015), pp. 1098-1107 View in ScopusGoogle Scholar
  • D. Shimbo, N.T. Artinian, J.N. Basile, R. Krakoff Lawrence, L. Margolis Karen, K. Rakotz Michael, et al. Self-measured blood pressure monitoring at home: A joint policy statement from the American Heart Association and American Medical Association Circulation, 142 (2020), pp. e42-e63 Google Scholar
  • A. Timmis, N. Townsend, C.P. Gale, A. Torbica, M. Lettino, S.E. Petersen, et al. European Society of Cardiology: Cardiovascular disease statistics 2019 Eur Heart J., 41 (2020), pp. 12-85 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
Fonte de datos: Dialnet